Research Paper Volume 15, Issue 20 pp 11217—11226
Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia
Figure 5. Differences in biological characteristics and treatment response between high- and low-risk score groups. (A) Infiltration levels of 22 immune cells. (B) Enrichment scores of cancer-related hallmark gene sets. (C) Differences in CS-score between high-and low-risk score groups. (D, E) Therapeutic sensitivity of two commonly used chemotherapeutic drugs for AML. (F) Response prediction to immunotherapy (anti-PD-1 and anti-CTLA4) between the low- and high-risk score groups. *P < 0.05.